Challenges and progress in the development of a serogroup B meningococcal vaccine

被引：3

作者：

Lewis, Susan ^{[1
]}

Sadarangani, Manish ^{[1
]}

Hoe, J. Claire ^{[1
]}

Pollard, Andrew J. ^{[1
]}

机构：

[1] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Dept Paediat,Oxford Vaccine Grp, Oxford OX3 7LJ, England

来源：

EXPERT REVIEW OF VACCINES | 2009年 / 8卷 / 06期

关键词：

5CVMB; meningococcal disease; outer membrane protein; outer membrane vesicle vaccine; serogroup B; MEMBRANE-VESICLE VACCINE; INNER-CORE LIPOPOLYSACCHARIDE; MENINGITIDIS GROUP-B; H-BINDING PROTEIN; SYNERGISTIC BACTERICIDAL ACTIVITY; NEISSERIA-LACTAMICA PROTECTS; HUMAN-ANTIBODY RESPONSES; HUMAN SERUM ANTIBODIES; NEW-ZEALAND; ESCHERICHIA-COLI;

D O I：

10.1586/ERV.09.30

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Serogroup B meningococci cause the majority of the meningococcal disease burden in developed countries. Production of an effective and safe vaccine for serogroup B organisms has been hampered by the poor immunogenicity of the capsular polysaccharide that defines this group of bacteria. Previous efforts have focused on outer membrane vesicle vaccines, which have been implemented successfully during clonal outbreaks. However, the search for a universal vaccine against endemic polyclonal serogroup B meningococcal disease continues. In this review, we have highlighted recent development of outer membrane vesicle vaccines and progress in the evaluation of recombinant outer membrane protein vaccines.

引用

页码：729 / 745

页数：17

共 50 条

[21] Meningococcal serogroup C conjugate vaccine
Lakshman, R
Finn, A
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) : 87 - 96
[22] Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic
Aaberge, IS
Oster, P
Helland, OS
Kristoffersen, AC
Ypma, E
Hoiby, EA
Feiring, B
Nokleby, H
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (05) : 599 - 605
[23] Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older
Byington, Carrie L.
Maldonado, Yvonne A.
Barnett, Elizabeth D.
Davies, H. Dele
Edwards, Kathryn M.
Lynfield, Ruth
Munoz, Flor M.
Nolt, Dawn L.
Nyquist, Ann-Christine
Rathore, Mobeen H.
Sawyer, Mark H.
Steinbach, William J.
Tan, Tina Q.
Zaoutis, Theoklis E.
PEDIATRICS, 2016, 138 (03)
[24] Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy
Morrone, Teresa
Napolitano, Francesco
Albano, Luciana
Di Giuseppe, Gabriella
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1921 - 1927
[25] The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
Semchenko, Evgeny A.
Tan, Aimee
Borrow, Ray
Seib, Kate L.
CLINICAL INFECTIOUS DISEASES, 2019, 69 (07) : 1101 - 1111
[26] Meningococcal serogroup B outbreaks and use of 4CMenB vaccine
Rose, Warren E.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2014, 54 (02) : 198 - +
[27] Vaccine prophylaxis after death by invasive serogroup B meningococcal infection
Malbranche, Charlotte
Maura, Geric
Pioud, Virginie
Theveniaud, Laurent
Guignard, Marie-Helene
PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 281 - 281
[28] Are physicians obligated to tell parents about the meningococcal serogroup B vaccine?
Robinson, Joan L.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2015, 26 (06): : 333 - 333
[29] Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study
Abara, Winston E.
Modaressi, Sharareh
Fireman, Bruce
Klein, Nicola P.
Layefsky, Evan
Goddard, Kristin
Bernstein, Kyle T.
Kirkcaldy, Robert D.
Zerbo, Ousseny
VACCINE, 2024, 42 (26)
[30] Meningococcal Serogroup B Vaccine Policies and Recommendations at US Colleges and Universities
Schwartz, Jason L.
Lawrence, Juliana C.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 59 (04) : 618 - 619

← 1 2 3 4 5 →